Advertisement

Liver Diseases pp 707-714 | Cite as

Management of Ascites

  • Michela Triolo
  • Vincenzo La MuraEmail author
Chapter

Abstract

Management of ascites ranges from diuretic treatment to liver transplantation. This chapter will describe the widely accepted strategies of treatment for uncomplicated and complicated ascites.

Keywords

Cirrhosis Ascites Hyponatremia Spontaneous bacterial peritonitis Hepatorenal syndrome Refractory ascites Transjugular intrahepatic portosystemic shunts 

References

  1. 1.
    Pericleous M, Sarnowski A, Moore A, Fijten R, Zaman M. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. Eur J Gastroenterol Hepatol. 2016;28(3):e10–8.CrossRefGoogle Scholar
  2. 2.
    Morando F, Rosi S, Gola E, Nardi M, Piano S, Fasolato S, Stanco M, Cavallin M, Romano A, Sticca A, Caregaro L, Gatta A, Angeli P. Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study. Liver Int. 2015;35:1508–15.CrossRefGoogle Scholar
  3. 3.
    Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int. 2018;12(Suppl 1):122–34.CrossRefGoogle Scholar
  4. 4.
    European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69:406.CrossRefGoogle Scholar
  5. 5.
    Lin S, Wang M, Zhu Y, Dong J, Weng Z, Shao L, Chen J, Jiang J. Hemorrhagic complications following abdominal paracentesis in acute on chronic liver failure: a propensity score analysis. Medicine (Baltimore). 2015;94(49):e2225.CrossRefGoogle Scholar
  6. 6.
    Elsabaawy MM, Abdelhamid SR, Alsebaey A, Abdelsamee E, Obada MA, Salman TA, Rewisha E. The impact of paracentesis flow rate in patients with liver cirrhosis on the development of paracentesis induced circulatory dysfunction. Clin Mol Hepatol. 2015;21:365–71.CrossRefGoogle Scholar
  7. 7.
    Bernardi M, Caraceni P, Navickis RJ. Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis? Expert Rev Gastroenterol Hepatol. 2017;11:191–2.PubMedGoogle Scholar
  8. 8.
    Cillo U, Burra P, Mazzaferro V, Belli L, Pinna AD, Spada M, Nanni Costa A, Toniutto P, I-BELT (Italian Board of Experts in the Field of Liver Transplantation). A multistep, consensus-based approach to organ allocation in liver transplantation: toward a “Blended Principle Model”. Am J Transplant. 2015;15:2552–61.CrossRefGoogle Scholar
  9. 9.
    Ali A, Farid S, Amin M, Kassem M, Al-Garem N. Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial. Hepatogastroenterology. 2014;61:1915–24.PubMedGoogle Scholar
  10. 10.
    Gow PJ, Ardalan ZS, Vasudevan A, Testro AG, Ye B, Angus PW. Outpatient terlipressin infusion for the treatment of refractory ascites. Am J Gastroenterol. 2016;111:1041–2.CrossRefGoogle Scholar
  11. 11.
    Bureau C, Adebayo D, Chalret de Rieu M, Elkrief L, Valla D, Peck-Radosavljevic M, McCune A, Vargas V, Simon-Talero M, Cordoba J, Angeli P, Rosi S, MacDonald S, Malago M, Stepanova M, Younossi ZM, Trepte C, Watson R, Borisenko O, Sun S, Inhaber N, Jalan R. Alfapump® system vs. large volume paracentesis for refractory ascites: a multicenter randomized controlled study. J Hepatol. 2017;67:940–9.CrossRefGoogle Scholar
  12. 12.
    Facciorusso A, Amoruso A, Neve V, Antonino M, Prete VD, Barone M. Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis. World J Hepatol. 2014;6:793–9.CrossRefGoogle Scholar
  13. 13.
    Rössle M. TIPS: 25 years later. J Hepatol. 2013;59:1081–93.CrossRefGoogle Scholar
  14. 14.
    Bureau C, Thabut D, Oberti F, Dharancy S, Carbonell N, Bouvier A, Mathurin P, Otal P, Cabarrou P, Péron JM, Vinel JP. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant free survival of patients with cirrhosis and recurrent ascites. Gastroenterology. 2017;152:157–63.CrossRefGoogle Scholar
  15. 15.
    Bercu ZL, Fischman AM, Kim E, Nowakowski FS, Patel RS, Schiano TD, Chang CY, Lookstein RA. TIPS for refractory ascites: a 6-year single-center experience with expanded polytetrafluoroethylene-covered stent-grafts. AJR Am J Roentgenol. 2015;204:654–61.CrossRefGoogle Scholar
  16. 16.
    Schepis F, Vizzutti F, Garcia-Tsao G, Marzocchi G, Rega L, De Maria N, Di Maira T, Gitto S, Caporali C, et al. Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis. Clin Gastroenterol Hepatol. 2018;16:1153–62.CrossRefGoogle Scholar
  17. 17.
    Møller S, Krag A, Bendtsen F. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes. Liver Int. 2014;34:1153–63.CrossRefGoogle Scholar
  18. 18.
    Minhtri K, Nguyen MK, Ornekian V, Kao L, Butch AW, Kurtz I. Defining the role of albumin infusion in cirrhosis-associated hyponatremia. Am J Physiol. 2014;307:G229–32.Google Scholar
  19. 19.
    Ekser B, Mangus RS. Spontaneous bacterial peritonitis. Lancet. 2017;389:735.CrossRefGoogle Scholar
  20. 20.
    Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G, International Club of Ascites. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64:531–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Medicina Interna, Istituto di Ricovero e Cura a carattere Scientifico (IRCCS) San DonatoUniversità degli Studi di MilanoSan Donato MilaneseItaly
  2. 2.Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, U.O.C. Medicina Generale Emostasi e Trombosi, Dipartimento di Scienze Biomediche per la SaluteUniversità degli studi di MilanoMilanItaly
  3. 3.CRC “A.M. and A. Migliavacca” Center for liver disease, Division of Gastroenterology and Hepatology, Fondazione IRCCS Cà Granda Ospedale Maggiore PoliclinicoUniversità degli studi di MilanoMilanItaly

Personalised recommendations